LONDON, December 30, 2024--(BUSINESS WIRE)--

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1.KEY INFORMATION

(a)Full name of discloser: Qube Research & Technologies Limited (b)Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree Direct Line Insurance Group plc (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure 27-12-2024 (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A" Yes - Aviva plc

2.POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 10 10/11p ordinary Interests Short positions Number % Number % (1)Relevant securities owned and/or controlled:  0.0  0.0 (2)Cash-settled derivatives:  0.0 15,242,175 1.16 (3)Stock-settled derivatives (including options) and agreements to purchase/sell:  TOTAL:  0.0 15,242,175 1.16

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  Details, including nature of the rights concerned and relevant percentages:

3.DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Story Continues

The currency of all prices and other monetary amounts should be stated.

(a)Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit (GBp)

(b)Cash-settled derivative transactions

Class of relevant security Product description

e.g. call option Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of securities Exercise price per unit (GBp) 10 10/11p ordinary Equity swap increasing a long position 16 250.40 10 10/11p ordinary Equity swap increasing a long position 760 253.10 10 10/11p ordinary Equity swap increasing a long position 993 254.10 10 10/11p ordinary Equity swap increasing a long position 1046 253.90 10 10/11p ordinary Equity swap increasing a long position 1251 253.50 10 10/11p ordinary Equity swap increasing a long position 2067 254.30 10 10/11p ordinary Equity swap increasing a long position 4837 252.20 10 10/11p ordinary Equity swap increasing a long position 5101 252.40 10 10/11p ordinary Equity swap increasing a long position 5493 254.40 10 10/11p ordinary Equity swap increasing a long position 6747 254.60 10 10/11p ordinary Equity swap increasing a long position 7826 254.20 10 10/11p ordinary Equity swap increasing a long position 12809 252.60 10 10/11p ordinary Equity swap increasing a long position 31110 252.80 10 10/11p ordinary Equity swap increasing a long position 31472 253.60 10 10/11p ordinary Equity swap increasing a long position 32843 253.20 10 10/11p ordinary Equity swap increasing a long position 38071 253.80 10 10/11p ordinary Equity swap increasing a long position 38185 253.00 10 10/11p ordinary Equity swap increasing a long position 52366 254.00 10 10/11p ordinary Equity swap increasing a long position 59308 253.40 10 10/11p ordinary Equity swap decreasing a long position 5 250.40 10 10/11p ordinary Equity swap decreasing a long position 922 254.80 10 10/11p ordinary Equity swap decreasing a long position 972 253.70 10 10/11p ordinary Equity swap decreasing a long position 985 254.10 10 10/11p ordinary Equity swap decreasing a long position 1076 252.70 10 10/11p ordinary Equity swap decreasing a long position 1158 253.90 10 10/11p ordinary Equity swap decreasing a long position 2040 252.20 10 10/11p ordinary Equity swap decreasing a long position 2200 252.90 10 10/11p ordinary Equity swap decreasing a long position 2721 254.60 10 10/11p ordinary Equity swap decreasing a long position 7563 254.40 10 10/11p ordinary Equity swap decreasing a long position 17275 254.00 10 10/11p ordinary Equity swap decreasing a long position 18914 252.40 10 10/11p ordinary Equity swap decreasing a long position 26268 253.60 10 10/11p ordinary Equity swap decreasing a long position 35022 252.60 10 10/11p ordinary Equity swap decreasing a long position 50678 253.40 10 10/11p ordinary Equity swap decreasing a long position 56834 253.80 10 10/11p ordinary Equity swap decreasing a long position 66665 252.80 10 10/11p ordinary Equity swap decreasing a long position 71763 253.20 10 10/11p ordinary Equity swap decreasing a long position 89635 253.00 10 10/11p ordinary Equity swap decreasing a long position 101856 254.20

(c)Stock-settled derivative transactions (including options)

(i)Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (GBp) Type

e.g. American, European etc. Expiry date Option money paid/ received per unit

(ii)Exercise

Class of relevant security Product description

e.g. call option Exercising/ exercised against Number of securities Exercise price per unit

(d)Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion Details Price per unit (if applicable)

4.OTHER INFORMATION

(a)Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None

(b)Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)the voting rights of any relevant securities under any option; or

(ii)the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none" None

(c)Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 30-12-2024 Contact name: Janice Falcao Telephone number: 00442033140679

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241230407415/en/

Contacts

Qube Research & Technologies LTD

View Comments